about
TWEAK promotes peritoneal inflammationFn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatinHSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosisTWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques.Proteomics in atherosclerosis.Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation.Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm.Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilationAnti-inflammatory and immunomodulatory effects of statins.Animal models of cardiovascular diseasesIdentification of novel biomarkers of abdominal aortic aneurysms by 2D-DIGE and MALDI-MS from AAA-thrombus-conditioned media.Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout miceN-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery DiseaseTweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasiaPlasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.Inflammatory biomarkers and statins.Quest for novel cardiovascular biomarkers by proteomic analysis.The cytokine TWEAK modulates renal tubulointerstitial inflammation.Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.TWEAKing renal injury.Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.A slit in podocyte death.Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.Considering TWEAK as a target for therapy in renal and vascular injury.Vascular proteomics, a translational approach: from traditional to novel proteomic techniques.Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.Proteomic and metabolomic profiles in atherothrombotic vascular disease.TWEAK and the kidney: the dual role of a multifunctional cytokine.Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.
P50
Q27318227-5A7D25C0-B9CD-438C-88EA-3F550FDFA706Q28249401-5F1086A8-9903-4663-AAC0-3BF46851097BQ28569716-79C17744-D563-4D8B-BC01-2C93835A1FA0Q28749137-1CF31344-0C18-4196-B94F-F40509ED331DQ31152445-800D7FCD-0459-4F95-BEFA-BBB350F9DA55Q33271663-CC155E09-3D69-466D-98DB-E8A47D61A307Q33276736-450B7119-7BF3-4199-B459-50306FB099E0Q33335986-43876EA6-402A-4612-8B83-DF92429EC6B4Q33393631-104AC756-2E70-4086-8A3C-1085EF473DEFQ33805812-AD263167-5BBB-4AF0-BA75-31FCA227AD67Q33944773-149A4313-739B-4300-88EB-DC688646FBAEQ34163404-42679507-0FB3-4147-86D0-2D6039022AF6Q34591282-DE04647E-6DFB-42EF-9EF5-4F205128E612Q34667533-EDB284D1-6E89-41FD-9AF5-350206181C12Q34751855-7D7E4C83-5FA3-4DBA-B751-CCEA447516AFQ35026182-DC29F218-D948-45E0-A869-D2DA016C8F27Q35026202-DCB6276D-80AF-4096-916A-99E1E0126E65Q35080598-BA8808B4-CB75-41F2-AFF4-77B0647DE2C1Q35689476-EE07FF20-1971-45B3-BA37-EA2C7A0C4B30Q35893298-270D5F02-A858-4C31-9ACA-2DCD3D7C11A1Q36015686-9EADF0CE-02EA-46CB-8E0D-4056C8F5B3CAQ36121799-45AD1583-94EE-4219-B9F1-6C9128227E21Q36219610-B5463A8F-3258-4F15-8D3B-B255F74F12D0Q36666882-876A338E-ACBD-484B-BF4A-15DF8390E94AQ36686970-8BEDDA20-A4D9-4C91-BD01-9E5639575A4AQ36813819-D24F42C7-DA6C-4E3B-BFA9-0755CF7FF161Q36985325-0D8EA203-131F-4977-9A05-21C0668FF7E4Q36991865-65E00527-EE6E-463A-B2F5-EC76EB92F6EEQ37042084-2920036A-858E-4F7D-B735-12A18757C3A2Q37232965-76121EB5-9698-4653-99BB-02D9EAB748A6Q37415728-72793D99-31F6-4F6B-A090-FF4EA1B41015Q37473770-6DA9CA2F-5270-4DA2-9319-EAD586302DC7Q37488099-61A542D9-CFCE-4A4D-98D7-333EE4D5E36DQ37494039-6379C9A3-A6C6-420D-AAC0-E536B4A11521Q37501679-2EB32D92-B233-4DA8-8F5D-50AB6D77FBA2Q37610301-A37BC3B0-1B1D-425A-8B43-8705B6421FD3Q37724036-1F51020C-F829-4EA6-8B87-23E66245F998Q37738351-A60FD3F9-BB31-4548-BFF2-FEE4BB6539ABQ37820359-97299B78-D41C-48EE-956F-D3B539B2B419Q37871569-AF57B40C-6D1D-413E-8E0F-FE388099DD66
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luis M Blanco-Colio
@ast
Luis M Blanco-Colio
@en
Luis M Blanco-Colio
@es
Luis M Blanco-Colio
@nl
Luis M Blanco-Colio
@sl
type
label
Luis M Blanco-Colio
@ast
Luis M Blanco-Colio
@en
Luis M Blanco-Colio
@es
Luis M Blanco-Colio
@nl
Luis M Blanco-Colio
@sl
prefLabel
Luis M Blanco-Colio
@ast
Luis M Blanco-Colio
@en
Luis M Blanco-Colio
@es
Luis M Blanco-Colio
@nl
Luis M Blanco-Colio
@sl
P106
P108
P21
P31
P496
0000-0002-1560-6609